Skip to content

Study of Metabolic Connectivity in Drug-resistant Temporal Epilepsy

Study of Metabolic Connectivity in Drug-resistant Temporal Epilepsy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05455047
Acronym
EPINE
Enrollment
90
Registered
2022-07-13
Start date
2022-02-01
Completion date
2022-06-01
Last updated
2022-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Brief summary

18F-Fluoro-deoxy-glucose (18F-FDG) positron emission tomography (PET) has a high sensitivity for temporal lobe epilepsy (TLE), the most common form of focal epilepsy, with a detection range of 86-90% . Therefore, 18F-FDG PET is a useful tool to identify the epileptogenic zone (ETZ) in the inter-ictal phase of drug-resistant temporal epilepsy during pre-surgical evaluation . Based on stereotactic electroencephalography (SEEG) findings, a correspondence between electrical data and metabolic changes on PET was found at the group level by identifying four different patterns of TLE . As expected, hypometabolism was not limited to the EZ defined by SEEG, but underlay broader epileptic networks . Because of the different electroclinical presentations of TLE, 18F-FDG PET appears to be a very useful tool in these temporal epilepsies. Indeed, it has been recently demonstrated that a gradient of PET hypometabolism from the uninvolved area to the spreading area, then to the epileptogenic area and to the lesion area is observed with consequently a good performance of 18F-FDG PET in defining the EZ . Therefore, it is interesting to study PET metabolism as a network and not as a combination of regional metabolic measures in epilepsy.

Interventions

DIAGNOSTIC_TESTPET-CT at 18F-FDG

PET-CT at 18f6FDG in nuclear medicine departement of Nancy's hospital

Sponsors

Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 56 Years

Inclusion criteria

* Patients with drug-resistant temporal epilepsy with an accurate diagnosis on SEEG * Patients with epilepsy who have had a PET/CT scan with 18F-FDG as part of a pre-operative assessment * Person having received complete information on the organization of the research and not having objected to the use of these data; * Patients affiliated to a social security system

Exclusion criteria

* Person who has not received full information on the organization of the research and who has opposed the use of this data * A person of full age who is the subject of a legal protection measure (guardianship, curatorship, safeguard of justice). * A person of full age who is unable to give consent and who is not subject to a legal protection measure

Design outcomes

Primary

MeasureTime frameDescription
Metabolic connectivity1 monthMetabolic connectivity of hypometabolic clusters in each temporal epilepsy subgroup defined by IRCA (interregional correlation analysis) and graph theory

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026